<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20130803014251N10</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-01-28</date_registration>
      <primary_sponsor>Abadan University of Medical Sciences</primary_sponsor>
      <public_title>Comparing the effects of painting therapy and aromatherapy with Rosa damascena Mill. on the management of anxiety, pain, and complications of tonsillectomy</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the effects of painting therapy, aromatherapy with Rosa damascena Mill., and aromatherapy with placebo on the management of anxiety, pain, and complications of tonsillectomy among children aged 6-12 years</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-01-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>84</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72667</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: First, each admitted participant will be allocated a number from 1-84. Then, participants will be stratified by age using the stratified method. Subsequently, participants of each stratify will be equally assigned to painting therapy, aromatherapy with Rosa Damascena Mill., and aromatherapy with placebo groups, utilizing the Stat Trek software with a random number generator. Randomization will be accomplished by a researcher assistant, who will be unaware of the aim of this trial and will be the only individual with access to group allocations.</study_design>
      <phase>3</phase>
      <hc_freetext>Condition 1: Anxiety. Condition 2: Surgical complications. Condition 3: Acute tonsillitis. Condition 4: Pain.</hc_freetext>
      <i_freetext>Intervention 1: First Intervention group: The participants in the first experimental group will receive surgical preparation and perioperative care based on the standard protocols of the recruitment hospitals. Additionally, they will receive a painting therapy program in two 20-minute sessions in the hospital and three 20-minute sessions after hospital discharge. Intervention 2: Second Intervention group: The participants in the first experimental group will receive surgical preparation and perioperative care based on the standard protocols of the recruitment hospitals. Additionally, they will receive an inhalation aromatherapy with two drops of Rosa damascena Mill. essence in two 20-minute sessions in the hospital and three 20-minute sessions after hospital discharge. Intervention 3: Control group: The participants in the control group will receive surgical preparation and perioperative care based on the standard protocols of the recruitment hospitals. Additionally, they will receive an inhalation aromatherapy with two drops of placebo (distilled water) in two 20-minute sessions in the hospital and three 20-minute sessions after hospital discharge.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only a part of patients' demographical data and main outcomes will be shared.

When:
After the publishing of the results

To whom:
Data will be available only for researchers working on academic and university associations.

Conditions:
Mention of study details and authors name

Where to obtain:
Morteza Nasiri: Department of Operating Room, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran

How to obtain:
Information will provide via the following email upon request. Mortezanasiri.or87@yahoo.com

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Masoomeh Asadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Building of Abadan University of Medical Sciences, Zulfaqari, 30M street, Abadan, Khuzestan province, Iran</address>
        <city>Abadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6319811154</zip>
        <telephone>+98 61 5338 4004</telephone>
        <email>M.asadi@abadanums.ac.ir</email>
        <affiliation>Abadan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Morteza Nasiri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.17, Fardanesh Alley, Qods Street, Enqelab Street, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>44361-14177</zip>
        <telephone>+98 21 8898 2905</telephone>
        <email>mnasiri@sina.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Desiring to participate in the research and complete the written consent form
Being 6-12 years old
Admitting to the hospital the night before the surgery
Undergoing tonsillectomy under general anesthesia and by dissection and snare approach
Having class I and II of the American Society of Anesthesiology (ASA)
Accessing to a smartphone to participate in follow-up sessions after hospital discharge</inclusion_criteria>
      <agemin>6 years</agemin>
      <agemax>12 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>A history of sensitivity to scents and perfumes
Having a disorder in the sense of smell
Presence of cognitive or mental disorders, heart diseases, and chronic pain based on medical records
Participation in previous courses of painting therapy or aromatherapy
A history of surgery and anesthesia
A history of tonsillectomy for another child in the family</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F06.4</hc_code>
      <hc_code>Y83.9</hc_code>
      <hc_code>J03.9</hc_code>
      <hc_code>R07.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Anxiety disorder due to known physiological condition</hc_keyword>
      <hc_keyword>Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure</hc_keyword>
      <hc_keyword>Acute tonsillitis, unspecified</hc_keyword>
      <hc_keyword>Pain in throat</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First Intervention group: The participants in the first experimental group will receive surgical preparation and perioperative care based on the standard protocols of the recruitment hospitals. Additionally, they will receive a painting therapy program in two 20-minute sessions in the hospital and three 20-minute sessions after hospital discharge.</i_keyword>
      <i_keyword>Second Intervention group: The participants in the first experimental group will receive surgical preparation and perioperative care based on the standard protocols of the recruitment hospitals. Additionally, they will receive an inhalation aromatherapy with two drops of Rosa damascena Mill. essence in two 20-minute sessions in the hospital and three 20-minute sessions after hospital discharge.</i_keyword>
      <i_keyword>Control group: The participants in the control group will receive surgical preparation and perioperative care based on the standard protocols of the recruitment hospitals. Additionally, they will receive an inhalation aromatherapy with two drops of placebo (distilled water) in two 20-minute sessions in the hospital and three 20-minute sessions after hospital discharge.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Tonsillectomy-induced anxiety. Timepoint: 4 steps: 1) the night before surgery in the hospitalized ward: before the start of the first intervention session as the first pre-test, 2) the day of surgery immediately before transferring the samples from the hospitalized ward to the operating room department: as the first post-test, 3) The day of surgery at the beginning of admitting the samples in the waiting room before surgery: before the start of the second intervention session as the second pre-test, 4) the day of surgery when lying on the surgery bed and immediately before induction of anesthesia: as the second post-test. Method of measurement: Modified Yale preoperative anxiety scale.</prim_outcome>
      <prim_outcome>Pain. Timepoint: The first three days after discharge from the hospital. Method of measurement: Numerical pain rating scale (or Wong-Baker faces pain rating scale).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Complications of tonsillectomy. Timepoint: The first three days after discharge from the hospital. Method of measurement: Researcher-made checklist.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Abadan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-08-05</approval_date>
        <contact_name>Ethics Committee of Abadan University of Medical Sciences</contact_name>
        <contact_address>Building of Abadan University of Medical Sciences, Zulfaqari, 30M street, Abadan, Khuzestan province, Iran Abadan Khouzestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
